BIOMAT Database Logo BIOMAT Database Logo

In vitro T cell function, delayed-type hypersensitivity skin testing, and CD4+ T cell subset phenotyping independently predict survival time in patients infected with human immunodeficiency virus. 1995

M J Dolan, and M Clerici, and S P Blatt, and C W Hendrix, and G P Melcher, and R N Boswell, and T M Freeman, and W Ward, and R Hensley, and G M Shearer
Department of Infectious Diseases, Wilford Hall Medical Center, Lackland Air Force Base, TX 78236-5300, USA.

Human immunodeficiency virus type 1 (HIV-1)-infected patients (n = 335) in the US Air Force HIV Natural History Program were followed for 3 years (mean) after skin testing, immunophenotyping of CD4+ cell subsets, and measurement of in vitro interleukin-2 production after stimulation by phytohemagglutinin, alloantigens, tetanus toxoid, and influenza A virus. The T cell functional assay predicted survival time (P < .001) and time for progression to AIDS (P = .014). Skin testing for tetanus, mumps, and Candida antigen and the total number of positive tests (P < .001 for each) stratified patients for survival time. In a multivariable proportional hazards model, the T cell functional assay (P = .008), the absolute number of CD4+ T cells (P = .001), the percentage of CD4+ CD29+ cells (P = .06), and the number of reactive skin tests (P < .001) predicted survival time. Thus, cellular immune functional tests have significant predictive value for survival time in HIV-1-infected patients independent of CD4+ cell count.

UI MeSH Term Description Entries
D006968 Hypersensitivity, Delayed An increased reactivity to specific antigens mediated not by antibodies but by sensitized T CELLS. Hypersensitivity, Tuberculin-Type,Hypersensitivity, Type IV,Tuberculin-Type Hypersensitivity,Type IV Hypersensitivity,Delayed Hypersensitivity,Delayed Hypersensitivities,Hypersensitivity, Tuberculin Type,Tuberculin Type Hypersensitivity,Tuberculin-Type Hypersensitivities,Type IV Hypersensitivities
D007111 Immunity, Cellular Manifestations of the immune response which are mediated by antigen-sensitized T-lymphocytes via lymphokines or direct cytotoxicity. This takes place in the absence of circulating antibody or where antibody plays a subordinate role. Cell-Mediated Immunity,Cellular Immune Response,Cell Mediated Immunity,Cell-Mediated Immunities,Cellular Immune Responses,Cellular Immunities,Cellular Immunity,Immune Response, Cellular,Immune Responses, Cellular,Immunities, Cell-Mediated,Immunities, Cellular,Immunity, Cell-Mediated,Response, Cellular Immune
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D008889 Military Personnel Persons including soldiers involved with the armed forces. Air Force Personnel,Armed Forces Personnel,Army Personnel,Coast Guard,Marines,Navy Personnel,Sailors,Soldiers,Submariners,Military,Force Personnel, Air,Personnel, Air Force,Personnel, Armed Forces,Personnel, Army,Personnel, Military,Personnel, Navy,Sailor,Soldier,Submariner
D011237 Predictive Value of Tests In screening and diagnostic tests, the probability that a person with a positive test is a true positive (i.e., has the disease), is referred to as the predictive value of a positive test; whereas, the predictive value of a negative test is the probability that the person with a negative test does not have the disease. Predictive value is related to the sensitivity and specificity of the test. Negative Predictive Value,Positive Predictive Value,Predictive Value Of Test,Predictive Values Of Tests,Negative Predictive Values,Positive Predictive Values,Predictive Value, Negative,Predictive Value, Positive
D011379 Prognosis A prediction of the probable outcome of a disease based on a individual's condition and the usual course of the disease as seen in similar situations. Prognostic Factor,Prognostic Factors,Factor, Prognostic,Factors, Prognostic,Prognoses
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000163 Acquired Immunodeficiency Syndrome An acquired defect of cellular immunity associated with infection by the human immunodeficiency virus (HIV), a CD4-positive T-lymphocyte count under 200 cells/microliter or less than 14% of total lymphocytes, and increased susceptibility to opportunistic infections and malignant neoplasms. Clinical manifestations also include emaciation (wasting) and dementia. These elements reflect criteria for AIDS as defined by the CDC in 1993. AIDS,Immunodeficiency Syndrome, Acquired,Immunologic Deficiency Syndrome, Acquired,Acquired Immune Deficiency Syndrome,Acquired Immuno-Deficiency Syndrome,Acquired Immuno Deficiency Syndrome,Acquired Immuno-Deficiency Syndromes,Acquired Immunodeficiency Syndromes,Immuno-Deficiency Syndrome, Acquired,Immuno-Deficiency Syndromes, Acquired,Immunodeficiency Syndromes, Acquired,Syndrome, Acquired Immuno-Deficiency,Syndrome, Acquired Immunodeficiency,Syndromes, Acquired Immuno-Deficiency,Syndromes, Acquired Immunodeficiency

Related Publications

M J Dolan, and M Clerici, and S P Blatt, and C W Hendrix, and G P Melcher, and R N Boswell, and T M Freeman, and W Ward, and R Hensley, and G M Shearer
Delayed-type hypersensitivity skin testing in human immunodeficiency virus-infected pediatric patients.
August 1996, The Journal of pediatrics,
M J Dolan, and M Clerici, and S P Blatt, and C W Hendrix, and G P Melcher, and R N Boswell, and T M Freeman, and W Ward, and R Hensley, and G M Shearer
Identification of human immunodeficiency virus-infected individuals by delayed type hypersensitivity skin testing.
January 1998, Annals of clinical and laboratory science,
M J Dolan, and M Clerici, and S P Blatt, and C W Hendrix, and G P Melcher, and R N Boswell, and T M Freeman, and W Ward, and R Hensley, and G M Shearer
Human immunodeficiency virus status and delayed-type hypersensitivity skin testing in Ugandan children.
February 1999, Pediatrics,
M J Dolan, and M Clerici, and S P Blatt, and C W Hendrix, and G P Melcher, and R N Boswell, and T M Freeman, and W Ward, and R Hensley, and G M Shearer
Delayed-type hypersensitivity skin testing using third variable loop peptides identifies T lymphocyte epitopes in human immunodeficiency virus-infected persons.
October 1997, The Journal of infectious diseases,
M J Dolan, and M Clerici, and S P Blatt, and C W Hendrix, and G P Melcher, and R N Boswell, and T M Freeman, and W Ward, and R Hensley, and G M Shearer
In vivo delayed-type hypersensitivity skin test anergy in human immunodeficiency virus type 1 infection is associated with T cell nonresponsiveness in vitro.
October 1998, The Journal of infectious diseases,
M J Dolan, and M Clerici, and S P Blatt, and C W Hendrix, and G P Melcher, and R N Boswell, and T M Freeman, and W Ward, and R Hensley, and G M Shearer
Delayed-type hypersensitivity skin testing can predict CD4 count increase in HIV patients with poor immunologic response to HAART.
June 2003, Journal of acquired immune deficiency syndromes (1999),
M J Dolan, and M Clerici, and S P Blatt, and C W Hendrix, and G P Melcher, and R N Boswell, and T M Freeman, and W Ward, and R Hensley, and G M Shearer
CD4+ T cell surface CCR5 density and virus load in persons infected with human immunodeficiency virus type 1.
October 2000, The Journal of infectious diseases,
M J Dolan, and M Clerici, and S P Blatt, and C W Hendrix, and G P Melcher, and R N Boswell, and T M Freeman, and W Ward, and R Hensley, and G M Shearer
Loss of cytomegalovirus-specific CD4+ T cell responses in human immunodeficiency virus type 1-infected patients with high CD4+ T cell counts and recurrent retinitis.
April 2001, The Journal of infectious diseases,
M J Dolan, and M Clerici, and S P Blatt, and C W Hendrix, and G P Melcher, and R N Boswell, and T M Freeman, and W Ward, and R Hensley, and G M Shearer
Instability of delayed-type hypersensitivity skin test anergy in human immunodeficiency virus infection.
October 1995, Archives of internal medicine,
M J Dolan, and M Clerici, and S P Blatt, and C W Hendrix, and G P Melcher, and R N Boswell, and T M Freeman, and W Ward, and R Hensley, and G M Shearer
Cutaneous delayed-type hypersensitivity in patients with human immunodeficiency virus infection in Zaire.
January 1989, Journal of acquired immune deficiency syndromes,
Copied contents to your clipboard!